NDA[removed]S-003 Page 3 Rev[removed]

First Page		Document Content
Date: 2009-03-31 15:48:48 Amines Quinazolines AstraZeneca Gefitinib Morpholines Adverse effect Erlotinib Chemistry Organic chemistry Organofluorides		NDA[removed]S-003 Page 3 Rev[removed] Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 205,56 KB Share Document on Facebook

	Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No DocID: 1rqYi - View Document
	Microsoft WordDOCX DocID: 1rnqZ - View Document
	Beilage 1: Arzneimittelmonographien DocID: 1rinj - View Document
	SAFETY DATA SHEET Page 1 of Total 6 Date of Issue: August 2016 SDS No. FMC/RAD/1 SECTION 1 DocID: 1rdYu - View Document
	imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinib DocID: 1rdbp - View Document